Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 5th February 2021
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Product recall for Otadex Skin Cream
Otadex Skin Cream as the lidocaine content is marginally our of specification.

Lidocaine content is marginally out of specification.

The Veterinary Medicines Directorate (VMD) has issued a product defect recall alert for Otadex Skin Cream manufactured by PetLife International Ltd. 

In a news release, the VMD writes: 'We wish to make retailers and veterinary surgeons aware that Petlife International Ltd has initiated a Class II recall to retail level for the product Otodex Skin Cream as the lidocaine content is marginally out of specification.

'Petlife International Ltd is contacting retailers, veterinary surgeons and wholesale dealers to examine inventory immediately and quarantine products subject to this recall.'

The recall affects batches:

 

Batch No.
 Expiry date
E001 31/03/2021
E002 31/01/2021


For further information about the recall contact  Dr J M Ballany on +44 1333 720257 or email johnballany@btinternet.com

 

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.